Heterogeneity of Dendritic Cells in Colon and Non-small Cell Lung Cancer
NCT04789252 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 64
Last updated 2024-01-02
Summary
Prospective study with the use of biological samples. The centers involved are the Thoracic Surgery and Surgery 1 Units of the San Gerardo Hospital in Monza.
Conditions
Interventions
- BIOLOGICAL
-
Bioinformatics analysis of single cell transcriptomics data
1. Sample collection: Myeloid cell purification + Single cell sequencing 2. Primary analysis: QC sequencing data + Reads alignment + UMI quantification 3. Bioinformatics analysis: Quality Control (Number of genes, UMI content,%mitochondrial genes, % riboprotein genes,Filtering low quality cells) + Normalization and scaling (Normalization, Remove unwanted sources of variation, HVG detection) + PCA Clustering Markers (PCA and PC selection, Clustering, t-SNE, Differential expression for markers identification) 4. Validation: FACS analysis + immunohistochemistry
Sponsors & Collaborators
-
University of Milano Bicocca
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-09
- Primary Completion
- 2026-02-09
- Completion
- 2026-02-09
Countries
- Italy
Study Locations
More Related Trials
-
Transfected Dendritic Cell Based Therapy for Patients With Breast Cancer or Malignant Melanoma
NCT00978913 ·Status: COMPLETED ·Phase: PHASE1
-
Study With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal Carcinoma
NCT01348256 ·Status: UNKNOWN ·Phase: PHASE2
-
In Vitro Functional Modulation of Monocyte-derived Dendritic Cells of Patients With Cancer by Peptides
NCT02159937 ·Status: COMPLETED
-
Dendritic Cell Based Therapy of Malignant Melanoma
NCT00197912 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dendritic Cells in Lung Cancer
NCT00442754 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Vaccination With Poly-ICLC and Dendritic Cells in Patients With Pancreatic Adenocarcinoma
NCT01677962 ·Status: COMPLETED ·Phase: PHASE1
-
Personalized DC Vaccine for Lung Cancer
NCT02956551 ·Status: UNKNOWN ·Phase: PHASE1
-
A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)
NCT05809752 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Preoperative Intratumor Dendritic Cells Injection Immunotherapy for Patients With Pancreatic Cancer
NCT00795977 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study of Polyfunctionality of Anti-tumor T Lymphocytes in Cancerology: Potential Biomarker for Emerging Immunotherapies
NCT02880046 ·Status: UNKNOWN
-
Autologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal Cancer
NCT05261750 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Natural Dendritic Cell Vaccines in Metastatic Melanoma Patients
NCT01690377 ·Status: COMPLETED ·Phase: PHASE1
-
Lymphocytes Subpopulation in Cancer Patients
NCT02516371 ·Status: UNKNOWN ·Phase: NA
-
Dendritic Cell Vaccination in Patients With Advanced Colorectal Cancer
NCT00311272 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of a Dendritic Cell-based Cancer Vaccine in Melanoma
NCT01863108 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity and Safety of DCs in Breast Cancer
NCT03450044 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Tumor-specific T Cells in Lung Cancer
NCT02515760 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing
NCT01730118 ·Status: COMPLETED ·Phase: PHASE1
-
Dendritic Cells Loaded With Allogeneous Cell Lysate in Mesothelioma Patients
NCT02395679 ·Status: UNKNOWN ·Phase: PHASE1
-
Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate Cancer
NCT01897207 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dendritic Cell-based Immunotherapy in Treatment Gastric Cancer
NCT03410732 ·Status: UNKNOWN ·Phase: PHASE2
-
Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic Melanoma
NCT01875653 ·Status: TERMINATED ·Phase: PHASE3
-
DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer
NCT05680922 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Dendritic Cell-based Immunotherapy in Mesothelioma
NCT00280982 ·Status: COMPLETED ·Phase: PHASE1
-
Dendritic Cell Vaccination in Patients With Advanced Melanoma
NCT03092453 ·Status: COMPLETED ·Phase: PHASE1